v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Total revenues $ 34,470 $ 36,769 $ 108,215 $ 80,253
Costs and operating expenses:        
Cost of product revenue 9,786 6,867 29,577 15,403
Research and development 21,821 15,165 60,410 39,562
Selling, general and administrative 13,499 13,407 39,859 37,600
Total costs and operating expenses 45,106 35,439 129,846 92,565
Income (loss) from operations (10,636) 1,330 (21,631) (12,312)
Interest income 436 41 618 424
Other income, net 216 983 150 920
Income (loss) before income taxes (9,984) 2,354 (20,863) (10,968)
Provision for income taxes 8 110 125 121
Net income (loss) $ (9,992) $ 2,244 $ (20,988) $ (11,089)
Net income (loss) per share, basic (in dollars per share) $ (0.15) $ 0.03 $ (0.32) $ (0.17)
Net income (loss) per share, diluted (in dollars per share) $ (0.15) $ 0.03 $ (0.32) $ (0.17)
Weighted average common stock shares used in computing net income (loss) per share, basic (in shares) 65,426 64,628 65,271 64,452
Weighted average common stock shares used in computing net income (loss) per share, diluted (in shares) 65,426 67,741 65,271 64,452
Product revenue        
Revenues:        
Total revenues $ 28,042 $ 28,731 $ 93,376 $ 53,674
Research and development revenue        
Revenues:        
Total revenues $ 6,428 $ 8,038 $ 14,839 $ 26,579

Source